Expertise in
12
conditions

Kazuteru Ohashi

Tokyo, JP 
Expertise in
12
conditions
Tokyo, JP 

Overview

Kazuteru Ohashi practices practicing medicine in Tokyo, Japan.

Ohashi is highly rated in 12 conditions, according to our data. Their clinical expertise encompasses Graft Versus Host Disease (GvHD), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

They are actively involved in clinical research, co-authoring 269 peer reviewed articles and participating in 1 clinical trial.

Locations

Tokyo, Japan
Other Locations
Komagome, Japan
Okayama, Japan
Honkomagome, 1138677, Japan
Sapporo, 0600818, Japan
Bunkyo, Japan
Komagome, Japan
Tsukuba, Japan
Shizuoka, 4228526, Japan
Kashihara, Japan
Nishinomiya-hama, Japan
Yokohama, 2238522, Japan
Kashiwa, 2778561, Japan
Fukuyama, 7290292, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy
A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Phase: Phase 3

269 Total Publications

Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols.
Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols.
Journal: Leukemia research
Published: June 03, 2024

Frequently Asked Questions about Kazuteru Ohashi

Is Kazuteru Ohashi a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Kazuteru Ohashi is classified as an Elite expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kazuteru Ohashi participate in research or clinical trials?

Yes. Kazuteru Ohashi has published 269 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Kazuteru Ohashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ohashi's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile